Real-world effectiveness and causal mediation study of BNT162b2 on long COVID risks in children and adolescents
Covid19-Sources
BKK Gesundheitsreport 2024 "Spurwechsel Prävention"
Intranasal Multiepitope PD‐L1‐siRNA‐Based Nanovaccine: The Next‐Gen COVID‐19 Immunotherapy
Clinical and functional assessment of SARS-CoV-2 sequelae among young marines – a panel study
Tissue-based T cell activation and viral RNA persist for up to 2 years after SARS-CoV-2 infection
Bluesky Nanovacination
Estimating the population-level effects of nonpharmaceutical interventions when transmission rates of COVID-19 vary by orders of magnitude from one contact to another
Long-term dysregulation of plasma peptidome in mild and multiple COVID-19 recovered patients revealed by a novel efficient peptidomics workflow
The impact of vaccination status on post-acute sequelae in hospitalized COVID-19 survivors using a multi-disciplinary approach: An observational single center study
Patient-Reported Treatment Outcomes in ME/CFS and Long COVID: ST2 Treatment Responses
PREPRINT RELEASE and Supplementary Data
One of the best responses was from an HIV antiviral. The worst response, by far, was "graded exercise".
Oncogenic potential of SARS-CoV-2—targeting hallmarks of cancer pathways - Cell Communication and Signaling
Study Links Inadequate Infection Prevention Staffing to Higher Infection Rates
The effect of the pandemic on colorectal cancer in the United States: An increased disease burden
Do N95s and KN95s filter viruses?
BCG Vaccine May Protect Against Long COVID Symptoms
(ISMRM 2024) The long-term cerebral change of patient transformed from mildly into severely emotional problem after multiple COVID-19 infections: 3-6 months
COVID-19 and Cardiac Arrhythmias: Lesson Learned and Dilemmas
Behandlung
Long COVID: Ansammlung des Spike-Proteins mit dauerhaften Auswirkungen auf das Gehirn verbunden
Astodrimer sodium nasal spray forms a barrier to SARS-CoV-2 in vitro and preserves normal mucociliary function in human nasal epithelium
Quantification of Objective Concentrations of DNA Impurities in Mrna Vaccines
Our results reproducibly confirm DNA:RNA mass ratios of 1:1000 which is consistent with the specifications of the approved mRNA vaccine product. We demonstrate that earlier published claims of 534-fold higher amounts of DNA impurities in vaccine mRNA prodcuts are not correct and a consequence of extraordinary high RNA and lipid concentrations. According to our data, gathered by applying different, orthogonal methods, we provide evidence that the concentration of product-related DNA impurities in both approved mRNA vaccines, BNT162b2 (Comirnaty) and mRNA-1273 (Spikevax) coincide with the approved mRNA specifications.
Post COVID: Expertin setzt Hoffnung in Medikament gegen Neuromyelitis Optica
Living systematic reviews psychotherapie und rehasport koennten bei long covid helfen
Comparison of mortality and cardiovascular complications due to COVID-19, RSV, and influenza in hospitalized children and young adults - PubMed
The Cardiac pathophysiology of Covid-19 | Brazilian Journal of Case Reports
Evolution of enhanced innate immune suppression by SARS-CoV-2 Omicron subvariants
Interventions for the management of long covid (post-covid condition): living systematic review
Clinical outcomes among patients infected with Omicron (B.1.1.529) SARS-CoV-2 variant in southern California